This is a regulatory disclosure made by Divi's Laboratories Limited to the National Stock Exchange of India Limited and BSE Limited.
The company has intimated that a meeting of its Board of Directors is scheduled to be held on Saturday, August 01, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026.
The disclosure confirms that the Trading Window for dealing in the securities of the Company has been closed since July 01, 2026, as per a previous intimation. This closure will remain in effect until 48 hours after the declaration of the financial results for the subject quarter. Consequently, the trading window is stated to remain closed until August 03, 2026.
This intimation is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The letter is signed by M. Satish Choudhury, who holds the designations of Company Secretary & Compliance Officer.